Posted by AGORACOM-JC
at 7:53 AM on Thursday, July 11th, 2019
Announced that it has hired a mobile processing company to travel to Portland Oregon from Washington State to process last year’s hemp crop.
The total amount to be processed is approximately 1,700 lbs of bio-mass and should take about 5 days to process. The anticipated the value of the crop is $250,000 USD.
VANCOUVER, British Columbia, July 11, 2019 — BOUGAINVILLE VENTURES INC. (“Bougainville” or the “Company”) (CSE: BOG) (8BV-FF:Frankfurt Stock Exchange) – The Company is pleased to announce that it has hired a mobile processing company to travel to Portland Oregon from Washington State to process last year’s hemp crop. The total amount to be processed is approximately 1,700 lbs of bio-mass and should take about 5 days to process. The anticipated the value of the crop is $250,000 USD.
Andy Jagpal, President Comments:
“This is a great day and milestone reached by our company. Not only
have we completed on our LOI with Worm Casting, and planted a successful
second crop for 2019, but we are in the midst of reporting revenue this
year by processing last year’s crop. The estimated value is expected to
be $250,000 USD and could be reported as early as the 4th quarter of
2019. To be reporting revenue only after a year of trading is quit the
accomplishment for a junior company. Also, the relationship we have
established with the mobile processing company will also be able to
process this year’s harvest as well.â€
Please visit the link below to view a video of the Oregon Hemp Farm:
About Mobile Processor The extraction company has
a mobile extraction laboratory and extractor to service the cannabis
sector. The type of services which can be performed on these mobile
platforms include: dehydration of plant material, cannabis grinding,
solvent-based extraction and filtration, fractional distillation, and
odor elimination.
About Bougainville Ventures, Inc.Bougainville
Ventures Inc. is dedicated to rapid growth in production, processing,
retail and branding of cannabis and cannabis related products. Currently
the company provides strategic capital to the thriving cannabis
cultivation sector through ownership and development of commercial real
estate properties. We offer fully built out turnkey facilities equipped
with state-of-the-art growing infrastructure to cannabis growers and
processors. Also, the Company is focused on building a strong presence
in the hemp industry with the objective of extracting cannabinoids in
both Canada and the United States. Along with our flagship Hemp project
in Oregon State and the Greenhouse campus in Washington state, the
Company has proprietary formulas for cannabis edibles, topical, and
tinctures.
On behalf of the Board of Directors BOUGAINVILLE VENTURES INC.
Andy Jagpal, President and Director
For further information, please contact Andy Jagpal at [email protected]. Please note that our Toll free number has changed to 1-877-517-7816.
FORWARD LOOKING STATEMENTS: This news release
contains certain forward-looking statements within the meaning of
Canadian securities laws. Forward-looking statements are based on the
expectations and opinions of the Company’s management on the date the
statements are made. The assumptions used in the preparation of such
statements, although considered reasonable at the time of preparation,
may prove to be imprecise and, as such, undue reliance should not be
placed on forward-looking statements. The Company expressly disclaims
any intention or obligation to update or revise any forward-looking
statements whether as a result of new information, future events or
otherwise.
No regulatory authority has approved or disapproved the information contained in this news release.
Tags: CBD, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in Bougainville Ventures | Comments Off on Bougainville Ventures $BOG.ca Hires Processing Company to Process the First 1,700 lbs of Hemp $CROP.ca $VP.ca NF.ca $MCOA
Posted by AGORACOM-JC
at 12:35 PM on Tuesday, July 9th, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.
NBUD: CSE
—————
Consumer Entry into the Cannabis Market Spikes Post Legalization
Global marijuana market was valued at USD 42.20 Billion in 2016. By 2025, the market is expected to reach USD 466.81 Billion while registering a CAGR of 35.3% from 2018 to 2025.
NEW YORK, July 9, 2019 — Within the first quarter of legalization, 5.3 million or 18% of Canadian ages 15 years and older reported using cannabis, according to Statistics Canada. Following legalization, a large number of new users were willing to try cannabis solely because it was legalized and readily accessible. However, a year prior to legalization, only around 14% of Canadians reported using the plant. During the quarter, approximately 646,000 of the users reported trying cannabis for the first time, rising dramatically when compared to 327,000 users a year prior. Overall, the rise year-over-year is largely due to the abundance of male users between the ages of 45 to 64.
Generally, within that age group, adults tend to use cannabis for
medical purposes, largely due to medical conditions associated with
aging. For instance, cases such as chronic pain, Alzheimer’s, and
Parkinson’s are typically associated with the older generation. And
through extensive studies, researchers have discovered that cannabis can
be used to treat these and several other medical conditions.
Furthermore, based on gender, a more significant amount of males used
cannabis when compared to females and it was estimated that 22.3% of
Canadian males used cannabis compared to only 12.7% of females.
Now, while the large increase in users is largely attributable to the
older generation, cannabis is also much more prevalent among the
younger generation. Statistics Canada reported that 29.5% of Canadians
ages 15 to 24 years old used cannabis in the first quarter. Similarly,
approximately 28.7% of Canadians ages 25 to 34-year-olds also used
cannabis during the quarter.
While the adoption of cannabis grew among Canadians, it is important
to remember that the market is still maturing. And despite its
legalization, there are still many legal barriers imposed on the market,
restricting the growth of businesses. Nonetheless, the market is
projected to continually grow throughout the shortcoming years,
developing into a global industry leader. And according to data compiled
by Verified Market Research, the global marijuana market was valued at
USD 42.20 Billion in 2016. By 2025, the market is expected to reach USD
466.81 Billion while registering a CAGR of 35.3% from 2018 to 2025.
Tags: Cannabis, CBD, CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca – Consumer Entry into the #Cannabis Market Spikes Post Legalization $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca
Posted by AGORACOM-JC
at 11:27 AM on Monday, July 8th, 2019
SPONSOR: Bougainville
Ventures Inc (CSE: BOG) Converting irrigated farmland to
greenhouse-equipped farmland. Bougainville does not “touch the plantâ€
and only provides agricultural infrastructure as a landlord for
licensed marijuana growers. Click here for more info.
BOG:CSE —————————————
Canada’s cannabis supply issues are real, despite feds’ denial, says business professor
A Canadian business professor says Bill Blair, Minister of Border Security and Organized Crime Reduction, was simply wrong when he said Canada’s cannabis supply shortage was “non-existent.â€
A Canadian business professor says Bill Blair, Minister of Border Security and Organized Crime Reduction, was simply wrong when he said Canada’s cannabis supply shortage was “non-existent.â€
On Wednesday, Rod Phillips, Ontario’s minister of finance, and Doug
Downey, Ontario’s attorney general, criticized a federal cannabis supply
shortage when announcing Ontario will be licensing 50 new cannabis retail locations across Ontario.
Blair shot back, saying Ontario was “making excuses†and using a
“non-existent supply shortage,†for their slow success in subverting the
illegal cannabis market in the province.
Blair pointed to Health Canada data that showed in April alone, Canada’s overall cannabis inventory was 24 times more than total sales that month.
But Michael Armstrong, a professor at the Goodman School of Business
at Brock University, said the federal government is using seemingly
impressive data to skirt around the fact that there are still
significant supply issues in Canada.
“They are wildly incorrect to say there’s no cannabis shortage and
that there’s enough legal cannabis for those who want it,†Armstrong
said in an email.
Canada’s cannabis supply
Armstrong says the majority of Canada’s cannabis inventory, more than
85 per cent of it, is unfinished — that means raw cannabis product that
has not been processed, packaged and made ready to sell.
Health Canada data shows that the majority of Canada’s cannabis supply is not ready to sell.
Health Canada
Some of that inventory may also never be ready to sell.
“Some of it, unfortunately, may not be sellable, whether that’s
contamination or microbial risk or pesticides or anything of that
nature,†said John Fowler, president of Supreme Cannabis and vice-chair of the Cannabis Council of Canada,
a cannabis business association. “The law does not allow licensed
producers to sell that product but it also doesn’t require them to
immediately destroy it.â€
Armstrong also criticized Blair and Health Canada for equating sales of legal cannabis with national demand.
“Sales isn’t the relevant measure of demand here, because legal sales
satisfy just a fraction of total consumption; most is met by black
markets,†Armstrong says.
Legal marijuana retailers are competing with illegal dealers,
Armstrong says, so to use legal sales as a benchmark for demand in
Canada is wrong.
“No one really knows how big the black market is and how much total consumption there is,†Armstrong said.
Nevertheless, he has estimated, using Health Canada data from a
report they commissioned on estimated cannabis use in the fall, overall
demand of dried cannabis, including illegal and medical sales, would
land somewhere around 56,000 kilograms a month.
Health Canada has been tracking cannabis sales since legalization on
their website. Numbers for April show dried cannabis sales reached just
below 9,000 kilograms, leaving just over 13,000 kilograms inventory
available to sell.
WATCH: Industry experts: Education on cannabis edibles needed
If Armstrong’s numbers are correct, this would leave a 43,000 kilogram gap that may have been filled by illegal sales.
“They’re looking at sales as their consumption. Businesses often do
that — they look at ‘are we keeping up with sales,’ but they’re doing
that when they have a healthy industry where sales is almost equal to
demand,†Armstrong said.
Blair’s team said Health Canada is holding up their end of the bargain when it comes to licensing producers.
As of March 31, 2019, Health Canada says federally licensed
cultivators are reporting nearly 700,000 square metres of land under
active cultivation, which can produce 1 million kilograms of cannabis
per year.
“This is roughly equivalent to estimates of the total quantity of
cannabis (legal and illegal) consumed in Canada, made by independent
market analysts, the Parliamentary Budget Officer and federal government
departments,†said Marie-Emmanuelle Cadieux, senior communications
advisor for Blair.
But Armstrong maintains that the numbers show the industry is continuing to have trouble meeting demand.
Getting cannabis on the shelves
In the past, Health Canada has acknowledged that Canada’s supply
issues don’t lie with the creation of the product, but rather with the
production process itself.
What exactly is wrong with production is a bit of a mystery,
Armstrong said. Whether it’s that producers are not growing high enough
volumes of quality cannabis that can turn into dry cannabis, or they
don’t have production facilities, or there are still issues with
shipping, Armstrong said he can only speculate.
“Big inventories are not translating into shipments going out the door,†Armstrong said.
Armstrong said that issues with federally mandated labelling could
have also slowed things down. He also guessed that certain producers
focused on getting greenhouses ready for marketing purpose rather than
setting up a production line that could handle orders coming in from
huge markets like the Ontario Cannabis Store.
John Fowler, is chalking production issues up to growing pains of a new market.
“I think, overall, things have been working pretty well,†said
Fowler. “Perhaps there was a lack of understanding of the complexity,
not just regulatory complexity of license approvals, but just building
the businesses and the supply chains to go from a market that literally
didn’t exist on October 17th.â€
Fowler said at this point, every part of the industry is being
stretched. It’s taking time to get licenses for smaller growers, as well
as licenses to expand growing spaces, and packaging and equipment
manufacturers are also being weighed down by a huge surge in demand.
“It’s one of those things it’s not one issue that’s holding the industry back from meeting its growth objectives.â€
When it comes to whether it’s a smart strategy to limit the amount of
cannabis stores in Ontario because of a production issue, Armstrong
says Ontario may be shooting themselves in the foot, considering
provinces like Alberta and British Columbia will have booming markets
with retailers ready to receive the inventory when it’s ready to sell.
But he says, they aren’t wrong in their reasoning for doing so.
“When they say that there’s not enough supply and there’s massive shortages, absolutely, that is correct.â€
In the end, Fowler doesn’t believe these delays, whether to overall
supply or to Ontario’s cannabis stores, will mean much to an industry
that’s meant to last.
“I think cannabis stores hopefully are going to be here for the next
100 years in this province. So a little bit of a six-month delay in
launch to be better for the next ninety-nine-and-a-half years. You know,
I don’t think it is a bad decision.â€
The Minister of Finance did not respond to a request for comment for this story.
Posted by AGORACOM-JC
at 7:16 AM on Monday, July 8th, 2019
Company’s clinic division, Sun Valley Health, has completed it’s 2019 Franchise Disclosure Document (FDD) and has commenced selling Sun Valley Health franchises in the United States
VANCOUVER, July 8, 2019 - EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics, is pleased to announce that the Company’s clinic division, Sun Valley Health, has completed it’s 2019 Franchise Disclosure Document (FDD) and has commenced selling Sun Valley Health franchises in the United States. Learn more at http://www.sunvalleyhealth.com
With the completion of the 2019 Franchise Disclosure Document (FDD)
the Company is now selling Sun Valley Health franchises and is accepting
franchise applications effectively immediately.
The Company has invested in the development of a new franchise trade
show booth that showcases the Sun Valley Health opportunity to
perspective franchisees using dynamic, content rich displays and four
(4) large format television monitors to present features and benefits to
the audience who attend the expos.
The franchise sales teams are booked to participate in the International Franchise Expo https://www.ifeinfo.com and the Cannabis Industry Marketplace Expo www.cannabisimp.com with nine (9) expos booked to showcase the Sun Valley Health franchise opportunity.
“Offering our years of experience in operating clinics to potential
franchise partners across America is an exceptional growth opportunity
for our Company, said Steven McAuley, CEO of Empower
Clinics Inc. “We have the opportunity to connect to exponentially more
patients who can benefit from direct access to physicians that provide
consultations on alternative treatment options.”
The upcoming expos are expected to generate significant interest in
the Sun Valley Health brand and it will allow the Company’s franchise
sales teams to communicate the benefits and opportunities the industry
can offer entrepreneurs, medical professionals and consumers in general.
The Company clinics offer consultations on the potential benefits of
CBD based treatment options to address a variety of qualifying
conditions including chronic pain, anxiety, PTSD, insomnia, indigestion
and other serious aliments that can affect the lives of so many people.
The Company also has commenced building retail product kiosks in all
clinics offering more than 40 products SKU’s that patients can purchase
in-clinic or online. All Sun Valley Health franchises will include
similar retail product kiosks that offer Sun Valley Health approved
products options.
“Our scientific approach to alternative medicine offers franchisees
& patients across America access to quality CBD, MMJ cards,
nutritional supplements, and holistic modalities with Physicians and
medical professionals on hand and available in our clinics.” said Dustin Klein, Empowers SVP, Business Development and Director.
Each Company owned clinic and all franchised clinics in our
nationwide network will offer a full range of CBD products and health
& wellness supplements, that provide a wide array of choices to
patients and customers in the communities we serve.
ABOUT EMPOWER
Empower is a leading multi-state operator of a network of
physician-staffed clinics focused on helping patients improve and
protect their health through innovative physician recommended treatment
options. Operating as a vertically-integrated health & wellness
brand with it’s first hemp-derived CBD extraction facility under
development, the Company can produce and package its proprietary line of
cannabidiol (CBD) based products and distribute through company owned
and franchised clinics, with wholesale partnerships, online and with
retailers nationwide.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley Chief Executive Officer
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements”
or “forward-looking information” (collectively “forward looking
statements”) within the meaning of applicable Canadian securities laws. All
statements, other than statements of historical fact, are
forward-looking statements and are based on expectations, estimates and
projections as at the date of this news release. Forward-looking statements
can frequently be identified by words such as “plans”, “continues”,
“expects”, “projects”, “intends”, “believes”, “anticipates”,
“estimates”, “may”, “will”, “potential”, “proposed” and other similar
words, or information that certain events or conditions “may” or “will”
occur. Forward-looking statements in this news release include
statements regarding; the Company’s intention to open a hemp-based CBD
extraction facility, the expected benefits to the Company and its
shareholders as a result of the proposed acquisitions and partnerships;
the terms of the proposed acquisitions and partnerships; the
effectiveness of the extraction technology; the expected benefits for
Empower’s patient base and customers; access to Empower’s home delivery
and e-commerce platform; the benefits of CBD based products; the effect
of the approval of the Farm Bill; the growth of the Company’s patient
list and that the Company will be positioned to be a market-leading
service provider for complex patient requirements in 2019 and beyond.
Such statements are only projections, are based on assumptions known to
management at this time, and are subject to risks and uncertainties that
may cause actual results, performance or developments to differ
materially from those contained in the forward-looking statements,
including; that the Company may not open a hemp-based CBD extraction
facility; that the hemp-based CBD extraction facility may not be fully
operation by Q2 2019 if at all; that legislative changes may have an
adverse effect on the Company’s business and product development; that
the Company may not be able to obtain adequate financing to pursue its
business plan; general business, economic, competitive, political and
social uncertainties; failure to obtain any necessary approvals in
connection with the proposed acquisitions and partnerships; and other
factors beyond the Company’s control. No assurance can be given that any
of the events anticipated by the forward-looking statements will occur
or, if they do occur, what benefits the Company will obtain from them.
Readers are cautioned not to place undue reliance on the forward-looking
statements in this release, which are qualified in their entirety by
these cautionary statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or revise any
forward-looking statements in this release, whether as a result of new
information, future events or otherwise, except as expressly required by
applicable laws.
Investors: Steve Low, Boom Capital Markets, [email protected], 647-620-5101; Investors: Steven McAuley, CEO, [email protected], 604-789-2146; For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARICopyright CNW Group 2019
Tags: CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca Commences Selling Franchises Under The Sun Valley Health Brand $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca
Posted by AGORACOM-JC
at 9:48 PM on Wednesday, July 3rd, 2019
The cannabis retail market represents a massive opportunity and it is much less saturated when compared to the cannabis cultivation opportunity
The company, Spyder Cannabis (SPDR: TSX Venture) recently completed a go-public transaction and has been flying under the radar
By Anthony Varrell
During the last year, the amount of interest in the legal cannabis
industry has significantly increased and most of this attention has been
focused on North America. This is a trend that we have been excited
about as it has benefited the companies that are levered to the
burgeoning cannabis market.
Earlier this month, we came across a cannabis business that is
focused on the North American cannabis retail opportunity. The cannabis
retail market represents a massive opportunity and it is much less
saturated when compared to the cannabis cultivation opportunity. The
company, Spyder Cannabis (SPDR: TSX Venture) recently completed a go-public transaction and has been flying under the radar.
Spyder Cannabis is an emerging opportunity that is focused on
expanding into legal cannabis and hemp industry. The company has
developed a scalable retail model that includes an aggressive expansion
plan that is focused on creating a significant retail footprint while
being highly focused on securing strategic partners.
Spyder Cannabis will utilize a targeting retail distribution strategy
and will focus on the cannabis retail opportunity in Canada and the US.
The company plans to open retail outlets in high-traffic locations and
we are favorable on this approach.
Spyder Cannabis: An Execution Story to be Watching
One of the reasons we are excited about Spyder Cannabis is due to the
focus on the cannabis opportunity in the US and Canada. These two
markets represent massive opportunities for the company and we are
bullish on the growth prospects associated with these markets. Spyder
Cannabis will be utilizing a specific strategy to capitalize on each
market and we find this to be significant. There are massive differences
between the Canadian and the US cannabis market which has made the
opportunity for Spyder even more significant.
An attractive aspect of Spyder Cannabis’ expansion plan is related to
its plans to partner with a variety of developers to sign lease
agreements for prime real estate in close proximity to senior living,
sporting venues and malls throughout the US. The company plans to
initially focus on the opportunity in California, Florida, Michigan and
New York, and we will monitor how the team is able to open new retail
outlets and increase market share in the US.
When a company is looking to open a cannabis retail operation, there
are countless factors that must be considered. We believe that Spyder
Cannabis has the right approach to opening locations and will monitor
how the team is able to execute on its expansion strategy. By targeting
the aging, athletics and health and wellness community, the company
should be able to de-risk its expansion plan and we find this to be
significant aspect of the story
Spyder Cannabis is developing a proprietary product line of
hemp-derived ointments, oils, capsules and topical creams for the aging,
sports and health and wellness space. The products will be sold
directly to consumers through both kiosks and retail stores throughout
the US. We are favorable on the markets the company is focused on and
the strategy to reach consumers. Over the next year, we expect the US
market to be a major value driver to Spyder Cannabis and this is an
opportunity that we will continue to monitor.
A US Cannabis Retail Expansion Story
When looking at Spyder Cannabis’ approach to capitalizing on the US
cannabis market, the first thing to stand out are the states that the
company is focused on. Currently, Spyder is executing on an expansion in
California, Florida, Michigan, and New York. These are four of the most
exciting markets in the US and we are favorable on the growth prospects
associated with these markets.
Spyder Cannabis is focused on opening branded boutique retail stores
and kiosks in burgeoning cannabis markets in the US. The company has
been working tirelessly on this expansion and has been successfully
increasing market share in the states that it has entered. Over the next
year, we expect to see the company build upon its existing footprint
and are favorable on the value that can be created through this
expansion.
By 2020, Spyder Cannabis plans to open between 30 to 50 boutique
retail stores and kiosks and has developed a cost-effective strategy in
order to execute on this. The company is focused on opening locations
that require a limited amount of capital expenditures that are in
secondary and tertiary markets and located in high-traffics areas.
Specifically, Spyder Cannabis plans to open stores that are located
close to malls, retirement centers, and sporting events.
A Canadian Expansion Story
When it comes to the Canadian cannabis opportunity, Spyder Cannabis
has been executing on a nationwide expansion and already has three
operational Spyder Vape stores open in Ontario. Over the next year, the
company plans to significant increase its reach in Canada and plans to
open 20 retail locations in Ontario, 5 retail locations in Alberta, and 5
retail locations in British Columbia.
Currently, there are two additional Spyder Vape stores under
construction in Ontario and we will monitor how the management team is
able to execute on this expansion. The company has been granted a
development permit for a retail location in Alberta and we are favorable
on the growth prospects associated with this market.
When it comes to the cannabis retail opportunity in Ontario, Spyder
Cannabis is strategically positioning itself throughout the province
through the opening of Spyder Vape stores. Once the company has received
the necessary permits, it plans to convert these outlets to cannabis
retail locations and we are favorable on the strategy in place.
Alberta represents a different type opportunity when it comes to the
cannabis retail market. Currently, there is a cannabis supply shortage
and the province has put a hold on issuing retail licenses. This has
caused a steep decline in the price of development permits and Spyder
Cannabis has been focused on acquiring permits for high-traffic
locations.
An Industry Leader in the Making
Spyder Cannabis wants to become the most recognizable brand of
independent retail stores and kiosks throughout North America. The
company is focused on offering best-in-class cannabis products and
tailored retail experiences in order to attract consumers and we are
favorable on this approach. Spyder Cannabis has strategic partnership
with more than 30 premium cannabis vendors and offers an industry
leading portfolio of cannabis products.
One of the reasons we are bullish on Spyder Cannabis is due to the
way that the management has positioned the business. The company is led
by an executive team that has a proven track record of success and that
has positioned the business to capitalize on the North American cannabis
market. We are favorable on the growth prospects associated with the
planned expansion and will monitor how the company continues to expand
across North America.
We are favorable on the strategic relationships that Spyder Cannabis
has been able to secure and find this to be an attractive aspect of the
story. From real estate partners to cannabis brand partners, the company
has done a fantastic job at pooling together its relationships to
support all facets of the business. Spyder Cannabis will be leveraging
its contacts for increased brand awareness and cross-selling
opportunities. We are favorable on this strategy when it comes to
becoming a leading cannabis brand and will be monitoring how the team
executes on this.
Spyder Cannabis is a company that has significant potential catalysts
for growth and this is an opportunity that we are excited about. To
learn more about the North American cannabis company, please reach out
to [email protected].
Pursuant to an agreement between StoneBridge Partners LLC and Spyder
Cannabis we have been hired for a period of 30 days beginning June 11,
2019 and ending July 11, 2019 to publicly disseminate information about
(SPDR) including on the Website and other media including Facebook and
Twitter. We are being paid $6,750 per month (SPDR) for or were paid
“ZERO†shares of unrestricted or restricted common shares. We own zero
(0) shares of (SPDR), which we purchased in the open market. We plan to
sell the “ZERO†shares of (SPDR) that we hold during the time the
Website and/or Facebook and Twitter Information recommends that
investors or visitors to the website purchase without further notice to
you. We may buy or sell additional shares of (SPDR) in the open market
at any time, including before, during or after the Website and
Information, provide public dissemination of favorable Information.
Posted by AGORACOM-JC
at 2:49 PM on Tuesday, July 2nd, 2019
WHY NORTHBUD FARMS?
Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
Infused products sector has become the highest margin segment of the industry
Positioned to be a raw input producer for this space
Currently working with multiple food, beverage and science companies to provide safe standardized cannabinoid infused raw inputs for large scale GMP manufacturing of products
In 2018, Eureka recognized revenue of approximately CAD$11.5 million*
net profit margin of 16%* from its California and Colorado operations
Anticipates further growth in revenue due to anticipated changes to retail regulation of adult cannabis use in California.
Justin Braune, CEO of Eureka Vapor, joins Scott to share the
company’s background and why Eureka was an ideal match for North Bud.
Watch until the end to hear Justin’s predictions on Federal
de-regulation in the US.
FULL DISCLOSURE: NORTHBUD is an advertising client of AGORA Internet Relations Corp.
Posted by AGORACOM-JC
at 8:32 AM on Tuesday, July 2nd, 2019
Announced that the Company’s manufacturing and distribution facility for its Viva Buds cannabis delivery service is expected to be completed and fully functional by August 2019.
Announced in April that it had acquired a 20% ownership interest in Natural Plant Extract of California to establish a joint venture to create Viva Buds Inc., a unique cannabis delivery service based in Los Angeles, California.
ESCONDIDO, Calif., July 02, 2019 –MARIJUANA COMPANY OF AMERICA INC. (“MCOA†or the “Companyâ€) (OTCQB: MCOA), an innovative hemp and cannabis corporation, today announced that the Company’s manufacturing and distribution facility for its Viva Buds cannabis delivery service is expected to be completed and fully functional by August 2019.
MCOA announced in April that it had acquired a 20% ownership interest
in Natural Plant Extract of California (“NPEâ€) to establish a joint
venture to create Viva Buds Inc., a unique cannabis delivery service
based in Los Angeles, California.
“We are making tremendous progress through our partnership with NPE
and the rollout of our licensed cannabis manufacturing facility,†said
Mr. Edward Manolos, Board Member of MCOA. “Our commitment to compliance
will put Viva Buds ahead of the competition in California at a time when
many license holders are still awaiting permits. Such permits are
difficult to attain for manufacturers currently using volatile
extraction methodologies, due to stringent regulations on California’s Manufactured Cannabis Safety.â€
“Our joint venture partnership with NPE will allow us to become more
competitive within the bourgeoning cannabis industry in Southern
California,†said Mr. Don Steinberg, CEO of MCOA. “Once completed and
launched, Viva Buds will offer consumers a line of high-quality products
at low prices along with the ability to build their own personal
cannabis business.â€
The Lynwood, California manufacturing facility is licensed for the
volatile manufacturing, distribution and retail delivery of cannabis
products. NPE’s volatile manufacturing process is an efficient and
cost-effective extraction process that will help distinguish NPE from
others that use extraction.
About Marijuana Company of America, Inc. MCOA is a
corporation that participates in: (1) product research and development
of legal hemp-based consumer products under the brand name “hempSMART™â€,
that targets general health and well-being; (2) an affiliate marketing
program to promote and sell its legal hemp-based consumer products
containing CBD; (3) leasing of real property to separate business
entities engaged in the growth and sale of cannabis in those states and
jurisdictions where cannabis has been legalized and properly regulated
for medicinal and recreational use; and, (4) the expansion of its
business into ancillary areas of the legalized cannabis and hemp
industry, as the legalized markets and opportunities in this segment
mature and develop.
About Natural Plant Extracts of California NPE
is a fully licensed cannabis manufacturing, distribution and non-store
front retail delivery. The Company has secured its licenses with the
state of California and city of Lynwood, CA. For more information about
the Company, please visit its website at https://nldistribution.com
The owners and founders of NPE are marijuana industry veterans with
decades of experience in establishing retail, manufacturing and
distribution of cannabis in California, including obtaining the first
retail dispensary licenses in Los Angeles, CA.
Legal Status of Cannabis While legalized in
California for recreational and medicinal use, cannabis remains a
Schedule 1 drug under the Controlled Substances Act (21 U.S.C. § 811)
and illegal under the federal law. Forward Looking Statements This
news release contains “forward-looking statements” which are not purely
historical and may include any statements regarding beliefs, plans,
expectations or intentions regarding the future. Such forward-looking
statements include, among other things, the development, costs and
results of new business opportunities and words such as “anticipate”,
“seek”, “intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or
similar phrases may be deemed “forward-looking statements” within the
meaning of the Private Securities Litigation Reform Act of 1995. Actual
results could differ from those projected in any forward-looking
statements due to numerous factors. Such factors include, among others,
the inherent uncertainties associated with new projects, the future U.S.
and global economies, the impact of competition, and the Company’s
reliance on existing regulations regarding the use and development of
cannabis-based products. These forward-looking statements are made as of
the date of this news release, and we assume no obligation to update
the forward-looking statements, or to update the reasons why actual
results could differ from those projected in the forward-looking
statements. Although we believe that any beliefs, plans, expectations
and intentions contained in this press release are reasonable, there can
be no assurance that any such beliefs, plans, expectations or
intentions will prove to be accurate. Investors should consult all of
the information set forth herein and should also refer to the risk
factors disclosure outlined in our annual report on Form 10-12G, our
quarterly reports on Form 10-Q and other periodic reports filed from
time-to-time with the Securities and Exchange Commission. For more
information, please visit www.sec.gov.
Posted by AGORACOM-JC
at 2:00 PM on Thursday, June 27th, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.
NBUD: CSE
—————
Cannabis industry expects bump in sales for Canada Day long weekend
Canada Day long weekend is no longer mostly the preserve of the liquor industry, say some of the country’s cannabis retailers.
More of the pie for that flag-waving party is being carved out by legal pot sellers as the first post-legalization national birthday approaches, says an online cannabis information resource.
By: Bill Kaufmann
The Canada Day long weekend is no longer mostly the preserve of the
liquor industry, say some of the country’s cannabis retailers.
More of the pie for that flag-waving party is being carved out by
legal pot sellers as the first post-legalization national birthday
approaches, says an online cannabis information resource.
A survey commissioned by Leafly Canada suggests 25 per cent of
Alberta adults plan to embark on a cannabis buzz this long weekend,
among the highest in the country.
“That’s one in four compared to one in five (nationally),†said Jo
Vos, managing director of Leafly Canada, which commissioned the poll of
1,513 people conducted last week by Maru/Blue.
“Alberta and Atlantic Canada are leading the country in plans to consume this weekend,†said Vos.
Among millennials surveyed — those aged 22 to 37 — a whopping 33 per
cent said they plan to toke up or consume edibles on Canada’s 152nd
anniversary weekend.
The latest Statistics Canada figures on cannabis consumption suggest
15 per cent of Canadians reported using pot in the past three months,
with 19 per cent planning to consume it over the next three months.
“That was a similar percentage to what was reported before legalization,†states StatsCan.
Those numbers rise to 33 per cent among those aged 18 to 24.
Cannabis information clearing house Leafly is confident legalization
is pushing cannabis use into the mainstream when weekends approach, said
Vos.
“We believe consumption patterns will continue to shift and there’s a
broader awareness of cannabis as an option,†she said, adding those
follow the lines of booze consumption.
“We know there are behaviour patterns very similar to alcohol in the lead-up to weekends.â€
There are even “very compelling†indications that cannabis could displace some alcohol use, added Vos.
It was illegal but now there’s a freedom,Mark Goliger
Some statistics on alcohol sales in Canada show they haven’t
decreased since pot legalization, but some predict that might happen
when cannabis-infused beverages come on the market at year’s end.
Vos acknowledged marketing the newly legalized product is a much
tougher task than that facing the alcohol industry, whose wares can be
promoted openly on a host of platforms, including newspaper ads and
street signage.
Legalization has grown Canadian cannabis demand “but not
exponentially,†said Mark Goliger, CEO of National Access Cannabis
(NAC), which operates 15 stores in Alberta.
But he said the first summer long weekend following prohibition’s end
will likely see a spike in people consuming pot, and those who do
should feel no stigma.
“It was illegal but now there’s a freedom,†said Goliger.
“Long weekends are a time for people to relax and enjoy more of
everything, whether it’s food, friends, drinks, cannabis and, hopefully,
sunshine.â€
NAC recently announced revenues of $40 million since legalization,
through its NewLeaf Cannabis stores in Alberta and other outlets in
Manitoba and Saskatchewan.
“We’d love to have been further ahead but with the (now-ended)
moratorium on new stores in Alberta, supply problems, with Ontario going
to a lottery system for new stores and B.C. not going as fast as we’d
like, it’s impacted things,†he said.
Cannabis retailers expect to sell plenty of the green stuff on the
first Canada Day long weekend since legalization.Ryan Remiorz / THE
CANADIAN PRESS
Posted by AGORACOM-JC
at 8:30 AM on Thursday, June 27th, 2019
Continued the expansion of its wholly owned subsidiary, hempSMART, Ltd., into Europe, with its latest launch in the Netherlands.
As a result of the positive feedback received during its United Kingdom launch in March, the Company made a strategic decision to offer its hempSMART™ CBD product line and expand its European footprint further by holding an event on June 15, 2019, in the Netherlands.
ESCONDIDO, Calif., June 27, 2019 — via NetworkWire – MARIJUANA COMPANY OF AMERICA, INC.(“MCOA†or the “Companyâ€) (OTCQB: MCOA), an innovative hemp and cannabis corporation, has continued the expansion of its wholly owned subsidiary, hempSMART, Ltd., into Europe, with its latest launch in the Netherlands.
As a result of the positive feedback received during its United
Kingdom launch in March, the Company made a strategic decision to offer
its hempSMART™ CBD product line and expand its European footprint
further by holding an event on June 15, 2019, in the Netherlands.
“The Netherlands launch was a complete success, with people traveling
from other parts of Europe to witness the excitement around our
hempSMART™ CBD product line,†said Mr. Ian Harvey, Global Sales Director
of hempSMART, Ltd. “The event featured our CEO, Don Steinberg,
unveiling our wellness products via video link and educating people
about the benefits of our prime quality botanical ingredients. Our
products sold out at the end of the event, and we engaged new marketing
associates for hempSMART™ as evangelists to the brand that will help
spread our vision.â€
“Our high-quality CBD products combined with our compilation of
highly knowledgeable hempSMART™ team members have effectively increased
the Company’s footprint into the compelling European market,†said Mr.
Steinberg.
The Brightfield Group, a predictive market intelligence firm focused
on the legal CBD and cannabis industries, opined on March 26, 2019, that
the European CBD market was estimated at $318 million in 2018 and is
expected to grow over 400 percent by 2023. Brightfield’s assessment was
based on its opinion that CBD is just starting to take hold in Europe,
and presents a great opportunity for developed brands to enter and
expand into.
About Marijuana Company of America, Inc. MCOA is
a corporation that participates in (1) product research and development
of legal hemp-based consumer products under the brand name hempSMART™,
which targets general health and well-being; (2) an affiliate marketing
program to promote and sell its legal hemp-based consumer products
containing CBD; (3) leasing of real property to separate business
entities engaged in the growth and sale of cannabis in those states and
jurisdictions where cannabis has been legalized and properly regulated
for medicinal and recreational use; and (4) the expansion of its
business into ancillary areas of the legalized cannabis and hemp
industry as the legalized markets and opportunities in this segment
mature and develop.
About Our hempSMART™ Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized
CBD as a safe and effective drug for any indication. Our products
containing CBD derived from industrial hemp are not marketed or sold
based upon claims that their use is safe and effective treatment for any
medical condition as drugs or dietary supplements subject to the
FDA’s jurisdiction.
Forward-Looking Statements This
news release contains “forward-looking statements†that are not purely
historical and may include any statements regarding beliefs, plans,
expectations or intentions regarding the future. Such forward-looking
statements include, among other things, the development, costs and
results of new business opportunities, and words such as “anticipate,â€
“seek,†intend,†“believe,†“estimate,†“expect,†“project,†“plan†or
similar phrases may be deemed “forward-looking statements†within the
meaning of the Private Securities Litigation Reform Act of 1995. Actual
results could differ from those projected in any forward-looking
statements due to numerous factors. Such factors include, among others,
the inherent uncertainties associated with new projects, the future U.S.
and global economies, the impact of competition and the Company’s
reliance on existing regulations regarding the use and development of
cannabis-based products. These forward-looking statements are made as of
the date of this news release, and we assume no obligation to update
the forward-looking statements, or to update the reasons why actual
results could differ from those projected in the forward-looking
statements. Although we believe that any beliefs, plans, expectations
and intentions contained in this press release are reasonable, there can
be no assurance that any such beliefs, plans, expectations or
intentions will prove to be accurate. Investors should consult all of
the information set forth herein and should also refer to the risk
factors disclosure outlined in our annual report on Form 10-K, our
quarterly reports on Form 10-Q and other periodic reports filed from
time to time with the Securities and Exchange Commission. For more
information, please visit www.sec.gov.
Tags: Cannabis, CBD, CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in Marijuana Company of America | Comments Off on Marijuana Company of America’s $MCOA #hempSMART™ Brand Continues European Expansion with Netherlands Launch $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca
Posted by AGORACOM-JC
at 8:46 AM on Wednesday, June 26th, 2019
Announced that the Company’s wholly owned subsidiary, hempSMART, Ltd., has successfully launched and generated sales from its hempSMART™ CBD product line in Scotland.
On June 22, 2019, the hempSMART UK team successfully sold out at its launch event, which led to the sign-up of numerous new marketing associates.
ESCONDIDO, Calif., June 26, 2019 – - MARIJUANA COMPANY OF AMERICA INC. (“MCOA†or the “Companyâ€) (OTCQB: MCOA), an innovative hemp and cannabis corporation, is pleased to announce that the Company’s wholly owned subsidiary, hempSMART, Ltd., has successfully launched and generated sales from its hempSMART™ CBD product line in Scotland.
On June 22, 2019, the hempSMART UK team successfully sold out at its
launch event, which led to the sign-up of numerous new marketing
associates. The Company’s launch event included an in-depth overview on
the education of the CBD industry and its hempSMART products, as well as
its marketing and compensation plans.
“We are delighted to report another milestone with the opening of
hempSMART and our expansion into Scotland,†said Mr. Ian Harvey, Global
Sales Director of hempSMART, Ltd. “There is a real demand for
high-quality CBD products throughout Europe, and the success
demonstrated from our sales in Scotland has confirmed this. After
Saturday’s event, Scotland is an ideal location for the hempSMART brand,
with future events and opportunity presentations already in place. I
personally didn’t expect to ever be a part of a new company that could
generate so much success and excitement in such a short period of time.â€
“We are excited to finally offer our premium line of CBD products to
the country of Scotland,†said Mr. Don Steinberg, CEO of MCOA. “It has
always been MCOA’s goal to open sales of its hempSMART products in
multiple countries around the world. Our Company anticipates additional
expansions of our footprint into other EU countries moving into the
second half of 2019.â€
About Marijuana Company of America, Inc. MCOA is a
corporation that participates in (1) product research and development
of legal hemp-based consumer products under the brand name “hempSMART™â€
and targets general health and well-being; (2) an affiliate marketing
program to promote and sell its legal hemp-based consumer products
containing CBD; (3) leasing of real property to separate business
entities engaged in the growth and sale of cannabis in those states and
jurisdictions where cannabis has been legalized and properly regulated
for medicinal and recreational use; and (4) the expansion of its
business into ancillary areas of the legalized cannabis and hemp
industry, as the legalized markets and opportunities in this segment
mature and develop.
About Our hempSMART Products Containing CBD The
United States Food and Drug Administration (FDA) has not recognized CBD
as a safe and effective drug for any indication. Our products containing
CBD derived from industrial hemp are not marketed or sold based upon
claims that their use is safe and effective treatment for any medical
condition as drugs or dietary supplements subject to the FDA’s
jurisdiction.
Forward Looking Statements This news
release contains “forward-looking statements” that are not purely
historical and may include any statements regarding beliefs, plans,
expectations or intentions regarding the future. Such forward-looking
statements include, among other things, the development, costs and
results of new business opportunities and words such as “anticipate,”
“seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan” or
similar phrases that may be deemed “forward-looking statements” within
the meaning of the Private Securities Litigation Reform Act of 1995.
Actual results could differ from those projected in any forward-looking
statements due to numerous factors. Such factors include, among others,
the inherent uncertainties associated with new projects, the future U.S.
and global economies, the impact of competition, and the Company’s
reliance on existing regulations regarding the use and development of
cannabis-based products. These forward-looking statements are made as of
the date of this news release, and we assume no obligation to update
the forward-looking statements, or to update the reasons why actual
results could differ from those projected in the forward-looking
statements. Although we believe that any beliefs, plans, expectations
and intentions contained in this press release are reasonable, there can
be no assurance that any such beliefs, plans, expectations or
intentions will prove to be accurate. Investors should consult all of
the information set forth herein and should also refer to the risk
factors disclosure outlined in our annual report on Form 10-12G, our
quarterly reports on Form 10-Q and other periodic reports filed from
time to time with the Securities and Exchange Commission. For more
information, please visit www.sec.gov.
